NASDAQ:DFTX | Profit Breakdown | Definium Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$75.08M-$158.99M
2026-03-31-$59.22M-$77.1M
2025-12-31-$47.58M-$50.44M
2025-09-30-$45.67M-$67.27M
2025-06-30-$40.9M-$42.74M
2025-03-31-$32.16M-$23.35M
2024-12-31-$32.46M-$34.74M
2024-09-30-$24.79M-$13.68M
2024-06-30-$24.46M-$5.85M
2024-03-31-$22.2M-$54.4M
2023-12-31-$22.21M-$23.86M
2023-09-30-$21.62M-$17.92M
2023-06-30-$29.18M-$29.13M
2023-03-31-$20.86M-$24.82M
2022-12-31-$13.9M-$4.9M-$4.9M
2022-09-30-$16.98M-$16.49M-$16.49M
2022-06-30-$16.94M-$16.96M-$16.96M
2022-03-31-$18.51M-$18.45M
2021-12-31-$17.56M-$17.99M-$16.83M
2021-09-30-$17.23M-$17.2M-$17.2M
2021-06-30-$45.22M-$45.25M-$45.25M
2021-03-31-$13.85M-$13.76M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$166.31M-$183.79M-$183.79M
2024-12-31-$103.92M-$108.68M-$108.68M
2023-12-31-$93.87M-$95.73M-$95.73M
2022-12-31-$66.33M-$56.8M-$56.8M
2021-12-31-$93.85M-$94.19M-$93.04M
2020-12-31-$33.03M-$33.94M-$33.94M
2019-12-31-$10.7M